Ajanta Pharma Limited is among the nation’s most prestigious pharmaceutical company, announcing their mission to serve the global healthcare with empathy, innovation and technology. The firm was established in the year of 1973 with headquarter at Mumbai. The company is announcing to ‘Serve Healthcare Needs Worldwide’. The company is aiming to use cutting edge technology to bring innovations.
The company is developing its business internationally to achieve their aim. The company is currently pursuing its business in India, USA and around thirty other countries in Asia, Africa, CIS and the Middle East. With a Research and Development team enriched with more than 750 scientists, Ajanta Pharma is possessing a workforce of more than 7,500 employees all over the world. The company has currently 1,400 products in different countries around the globe with a deep focus on the market of USA, expecting a good outcome. Ajanta Pharma has been manufacturing anti-malarial products for the health programmes in Africa approved by WHO.
Soon after its inception in 1973, Ajanta Pharma Limited has been pursuing tremendous achievements in its journey towards the golden jubilee. In 1979, the company produced branded ‘Over The Counter’ products along with developing its first manufacturing facility set-up at Chikalthana, India. By seven years the firm set up its second manufacturing facility at Paithan, India. By 1989, Ajanta Pharma reached a milestone of manufacturing more than 30 ‘Over The Counter’ products. The company intervened the international market for the first time in 1992. In 1995 the company developed its subsidiary at Mauritius with a manufacturing facility set-up. Millennium brought a credible achievement for the company while Ajanta Pharma had been enlisted in National Stock Exchange and Bombay Stock Exchange. The company intervened the domestic prescription market in 2002, introducing speciality segment force.
As the company has been in the process of in traducing innovations, it developed its R&D facility at Kandivli. Establishing an Active Pharmaceutical Ingredient (API) Plant at Waluj in Aurangabad, the company got the approval of USFDA in 2007. In the same year, Ajanta Pharma developed a manufacturing facility in Aurangabad for rapid growth. The company received its international recognition in the same year by becoming the world’s first generic company to achieve WHO Geneva Pre-qualification for Anti-Malarial Drug. In 2010, Ajanta Pharma intervened the market of the Philippines through Ajanta Philippines Inc. Ophthalmology, Dermatology, Cardiology— these are the three segments where the company created its reign and emerged in the leading position in 2011.
In the next year, the company achieved its place among the top ten pharmaceutical companies in Franco Africa. The company started its journey to explore the USA market in the year 2013. Ajanta Pharma inaugurated its Research & Development centre at Kandivli, Mumbai to expand its innovations and after that the business in a larger periphery. Inauguration of a new facility was done in Dahej, 2015 to fulfil the requirements of the USA market and WHO. Montelukas Sodium Oral Granules were announced to launch by Ajanta in 2015 along with the announcement of the launch of Montelukast IR Tablets and Montelukast Chewable Tablets in the US market. In the year 2017, the company developed its new facility in Guwahati. In the same year, USFDA has approved Ajanta Pharma’s Dahej facility.
The company is currently spending 9% of its revenue in Research & Development in the financial year of 2019-20. From 28 different nationalities, the company has appointed more than 7500 people as its permanent staff. The total income in the fiscal year of 2019-20 is 2076 crore INR; the company has been enjoying a net profit of 387 crore INR in the same financial year. The current EBITDA margin of the company in the current fiscal year of 2019-20 is 28%.
The company is announcing its philosophy as first to create opportunities and then optimize them on fullest.
How Ajanta Pharma Ltd, is categorised as Pharmaceuticals and Health Care Sector, and Pharmaceuticals Industry :
The Pharmaceutical Industry includes companies that derive their business by researching, discovering, developing, manufacturing, and marketing and distributing pharmaceutical medicines and drugs.
Ajanta Pharma Ltd is categorized under the Pharmaceutical and Health care sector and Pharmaceutical Industry. Healthcare sectors consist of firms involved in the medical space. It is one of the multiple sectors that comprise a range of businesses, including ones that offer medical services directly, or to those that work to develop, create and market medical equipment and medicines. It also includes the other services that provide medical insurance and other related products, and many more.
The stocks of health care companies mostly have mixed performance. It is due to the inherent challenges to the industry each year, regulatory uncertainties, fiscal policy concerns, and more.
Ajanta Pharma Ltd, Competitors and Sector Peers:
Alembic Pharmaceuticals Ltd. ALEPHA
Alkem Laboratories Ltd. ALKLAB
Alpa Laboratories Ltd. ALPLAB
Ambalal Sarabhai Enterprises Ltd. AMBSAR
AstraZeneca Pharma India Ltd. ASTZEN
Bafna Pharmaceuticals Ltd. BAFPHA
Bajaj Healthcare Ltd. BAJHEA
Concord Drugs Ltd. CONDRU
Dishman Pharmaceuticals & Chemicals Ltd.[Merged] DISPHA
Divi's Laboratories Ltd. DIVIL
Dr. Reddy's Laboratories Ltd. DR
GlaxoSmithKline Pharmaceuticals Ltd. GLAPHA
Glenmark Pharmaceuticals Ltd. GLEPHL
IOL Chemicals and Pharmaceuticals Ltd. IOLCHE
Lincoln Pharmaceuticals Ltd. LINPHA
Madhuveer Com 18 Network Ltd. TOHPHA
Mahavir Advanced Remedies Ltd. INDAME
Makers Laboratories Ltd. MAKLAB
Natural Capsules Ltd. NATCAP
Ranbaxy Laboratories Ltd. RANLAB
Sharon Bio-Medicine Ltd. SHAPHA
Sun Pharmaceutical Industries Ltd. SUN28
Zenith Healthcare Ltd. ZENHEA